PAPER Mill J
SEARCH RESULTS
329960 RESULTS
PAPER Yanagisawa D, Amatsubo T, Morikawa S, Taguchi H, Urushitani M, Shirai N, Hirao K, Shiino A, Inubushi T, Tooyama I
In vivo detection of amyloid β deposition using ¹⁹F magnetic resonance imaging with a ¹⁹F-containing curcumin derivative in a mouse model of Alzheimer's disease.
Neuroscience. 2011 Jun 16;184:120-7. PubMed: 21497641PAPER Rogers J, Mastroeni D, Grover A, Delvaux E, Whiteside C, Coleman PD
The epigenetics of Alzheimer's disease--additional considerations.
Neurobiol Aging. 2011 Jul;32(7):1196-7. PubMed: 21497949PAPER Tabarés-Seisdedos R, Dumont N, Baudot A, Valderas JM, Climent J, Valencia A, Crespo-Facorro B, Vieta E, Gómez-Beneyto M, Martínez S, Rubenstein JL
No paradox, no progress: inverse cancer comorbidity in people with other complex diseases.
Lancet Oncol. 2011 Jun;12(6):604-8. PubMed: 21498115PAPER Tikkakoski T
Advanced magnetic resonance imaging techniques in the diagnostics of Alzheimer's disease: how much imaging is enough?
Acta Radiol. 2011 Mar 1;52(2):127. PubMed: 21498338PAPER Li TQ, Wahlund LO
The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.
Acta Radiol. 2011 Mar 1;52(2):211-22. PubMed: 21498351PAPER Rapp K
People with Alzheimer's disease are at increased risk of hip fracture and of mortality after hip fracture.
Evid Based Nurs. 2011 Jul;14(3):78-9. PubMed: 21498878PAPER Riley KP, Jicha GA, Davis D, Abner EL, Cooper GE, Stiles N, Smith CD, Kryscio RJ, Nelson PT, Van Eldik LJ, Schmitt FA
Prediction of preclinical Alzheimer's disease: longitudinal rates of change in cognition.
J Alzheimers Dis. 2011;25(4):707-17. PubMed: 21498903PAPER Förster S, Buschert VC, Buchholz HG, Teipel SJ, Friese U, Zach C, La Fougere C, Rominger A, Drzezga A, Hampel H, Bartenstein P, Buerger K
Effects of a 6-month cognitive intervention program on brain metabolism in amnestic mild cognitive impairment and mild Alzheimer's disease.
J Alzheimers Dis. 2011;25(4):695-706. PubMed: 21498904PAPER Ago Y, Koda K, Takuma K, Matsuda T
Pharmacological aspects of the acetylcholinesterase inhibitor galantamine.
J Pharmacol Sci. 2011;116(1):6-17. PubMed: 21498956PAPER Zekry D, Herrmann FR, Graf CE, Giannelli S, Michel JP, Gold G, Krause KH
Mild cognitive impairment, degenerative and vascular dementia as predictors of intra-hospital, short- and long-term mortality in the oldest old.
Aging Clin Exp Res. 2011 Feb;23(1):60-6. PubMed: 21499020PAPER Nie Q, Du XG, Geng MY
Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease.
Acta Pharmacol Sin. 2011 May;32(5):545-51. PubMed: 21499284PAPER Chamberlain R, Wengenack TM, Poduslo JF, Garwood M, Jack CR
Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease.
Curr Med Imaging Rev. 2011 Feb;7(1):3-7. PubMed: 21499442PAPER Sun Y, Kim NH, Yang H, Kim SH, Huh SO
Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.
Mol Cells. 2011 May;31(5):483-9. PubMed: 21499833PAPER Farran CJ, Fogg LG, McCann JJ, Etkin C, Dong X, Barnes LL
Assessing family caregiver skill in managing behavioral symptoms of Alzheimer's disease.
Aging Ment Health. 2011 May;15(4):510-21. PubMed: 21500018Current Filters
No filters selected